Nora Fagan Selected Research

Antihypertensive Agents (Antihypertensives)

1/2014

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nora Fagan Research Topics

Disease

2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 01/2014
1	Infections 11/2023
1	Lupus Nephritis 11/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Hypopigmentation (Hypomelanosis) 01/2016
1	Eye Diseases (Eye Disease) 01/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Weight Loss (Weight Reduction) 01/2014

Drug/Important Bio-Agent (IBA)

2	SodiumIBA 01/2015 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2014
2	empagliflozinIBA 01/2015 - 01/2014
1	BI 655064IBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	GlucocorticoidsIBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	BI 6727IBA 01/2021
1	Decitabine FDA Link 01/2021
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2016
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2016
1	ropinirole (Requip)FDA LinkGeneric 01/2016
1	Therapeutic UsesIBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2015
1	Antihypertensive Agents (Antihypertensives)IBA 01/2014
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2014
1	Blood Glucose (Blood Sugar)IBA 01/2014

Therapy/Procedure

1	Glycemic Control 01/2015